{"id":158656,"date":"2025-06-04T22:44:14","date_gmt":"2025-06-04T22:44:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/158656\/"},"modified":"2025-06-04T22:44:14","modified_gmt":"2025-06-04T22:44:14","slug":"australias-medicines-regulator-has-approved-a-glp-1-weight-loss-drug-to-be-used-to-treat-sleep-apnoea","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/158656\/","title":{"rendered":"Australia\u2019s medicines regulator has approved a GLP-1 weight-loss drug to be used to treat sleep apnoea"},"content":{"rendered":"<p>The country\u2019s medicines regulator has approved the use of a GLP-1 weight-loss drug to treat people with sleep apnoea for the first time, broadening the applications for the popular drugs beyond diabetes and heart disease.<\/p>\n<p>Eli Lilly, the global pharmaceutical giant, said the Therapeutic Goods Administration had approved the use of its <a href=\"https:\/\/www.afr.com\/companies\/healthcare-and-fitness\/big-pharma-steps-up-push-for-taxpayer-funded-weight-loss-drugs-20250206-p5la1a\" target=\"_blank\" rel=\"noopener\">Mounjaro weight-loss drug<\/a> to treat moderate-to-severe obstructive sleep apnoea in adults with obesity.<\/p>\n<p>Loading&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"The country\u2019s medicines regulator has approved the use of a GLP-1 weight-loss drug to treat people with sleep&hellip;\n","protected":false},"author":2,"featured_media":158657,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,4326,16,15],"class_list":{"0":"post-158656","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114627520979660191","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/158656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=158656"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/158656\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/158657"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=158656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=158656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=158656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}